ClinicalTrials.gg
RecruitingNCT05240547Updated Nov 18, 2023

Chiropractic Spinal Manipulation for Headache

An interventional study of Spinal Manipulation and Placebo in Cervicogenic Headache and Tension-Type Headache, sponsored by Real Centro Universitario Maria Cristina. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 67 Years. Per ClinicalTrials.gov, last updated 2023-11-18.

Sponsored by Real Centro Universitario Maria Cristina · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2024, 2 years 5 months ago, but the record still lists the study as recruiting.
  • Started Feb 2022; still recruiting 4 years 8 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 67 Years
Sex
All
01

Study summary

This is a pilot and feasibility randomized controlled trial to assess the efficacy of chiropractic spinal manipulative therapy in patients with tension-type and cervicogenic headache.

Read the detailed description

This study is a pilot and feasibility randomized controlled trial that aims to assess the efficacy of 8 treatment sessions of chiropractic spinal manipulative therapy compared to the same number of sham manipulative therapy or placebo interventions for chronic cervicogenic and tension-type headache. The hypothesis proposed is that chiropractic care will reduce the intensity and frequency of both cervicogenic and tension-type headache episodes, when compared to placebo. A sample of 20 participants suffering from cervicogenic or tension-type headache for at least 3 months, aged 18 to 67 will be randomized to receive either 8 sessions of spinal manipulative treatment (2 times per week for a total of 4 weeks) or 8 sessions of a validated sham spinal manipulation. Outcomes will be assessed at baseline, after 4 treatments and at the end of the treatment period.

02

Conditions studied

  • Cervicogenic Headache
  • Tension-Type Headache
03

In context

Post-Traumatic Headache

192 studies on the registry are indexed under Post-Traumatic Headache; 54 are open to participants now.

This study's planned enrollment of 20 is below the median of 44 across 169 interventional studies indexed under Post-Traumatic Headache.

Browse Post-Traumatic Headache studies →

Lead sponsor

Real Centro Universitario Maria Cristina is the lead sponsor of 4 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 67 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • At least 2 episodes per month of cervicogenic or tension-type headache for at least 3 months. Diagnoses will be determined by case history and physical examination according to the International Headache Society criteria (3rd Edition)

Exclusion criteria

Exclusion Criteria:

  • Not fulfilling the inclusion criteria
  • Having received chiropractic treatment in the previous 12 months
  • Diagnosis or frequent symptoms of migraine headaches (symptoms present at least once a month) without an overlapping presentation of cervicogenic or tension-type headache.
  • Patients with pathologies affecting the nervous system (MS, tumors, past history of stroke...)
  • to manual therapy, particularly spinal manipulative therapy (cancer, uncontrolled high blood-pressure, severe cardiovascular conditions)
  • Past history of cervical spine surgery
  • Pregnancy
  • Having being diagnosed with a psychiatric conditions, with the exception of depression and anxiety
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    Spinal manipulation

    Spinal manipulative therapy will be delivered to the cervical spine (segments including occiput-atlas to C7-D1) according to the chiropractors' evaluation during each visit. During each session, one or two segments will be manipulated using a high-velocity low-amplitude thrust manipulation (a joint cavitation will be expected, if not, the thrust can repeated once) applied to the segments with the highest motion restriction, as determined by the chiropractor by static and motion palpation of the cervical spine.

    Other: Spinal Manipulation

  • Placebo comparator
    Placebo

    Sham manipulation will be delivered to the cervical spine (segments including occiput-atlas to C7-D1) according to the chiropractors' evaluation during each visit. During each session, one or two segments will receive a sham manipulation applied to the segments with the highest motion restriction, as determined by the chiropractor by static and motion palpation of the cervical spine. The sham manipulation will consist in a identical contact to the real manipulation, except the thrust will be delivered towards the table, away from the target segment and with the intention to lower the cervical drop piece of the table, which will substitute the joint cavitation noise.

    Other: Placebo

Interventions

  • OtherSpinal Manipulation

    Spinal manipulative therapy delivered to the cervical spine by a chiropractor

  • OtherPlacebo

    Sham manipulative treatment delivered to the cervical spine by a chiropractor

06

What researchers measure

Primary outcomes

  1. Pain intensity

    Pain intensity will be measured by showing patients a numerical rating scale from 0 (no pain at all) to 10 (maximum possible pain)

    Time frame: 4 weeks

  2. Pain frequency

    Chronic pain patients will describe whether their pain is episodic (pain-free periods of at least 4 week duration) or fluctuating (no pain-free periods of at least 4 week duration)

    Time frame: 4 weeks

Secondary outcomes

  1. Pain Catastrophizing Scale

    The Pain Catastrophizing Scale (PCS) provides the level of catastrophizing beliefs and emotions that a person has with regards to his/her own pain experience, in this case, low back pain. It includes 13 items rated on a Likert scale from 0-4. The total range of possible scores is from 0-52, where 0 is the lowest possible level of catastrophizing and 52 the highest.

    Time frame: 4 weeks

  2. Pressure pain thresholds

    Pressure pain thresholds (PPTs) are part of quantitative sensory testing. The aim is to identify the threshold and the sensitivity to suprathreshold pressure stimulation in different areas of the patients' bodies. An algometer will be used (Wagner Force Dial FDK20, Greenwich, CT, USA) to measure PPTs in the suboccipital muscles for each patient. The measure will be taken before and after treatment to determine the immediate effects of spinal manipulative therapy on pain sensitivity. this will be used to correlate with the changes in clinical pain.

    Time frame: 4 weeks

Other outcomes

  1. Sex

    Biological sex (Male or Female) for feasibility purposes

    Time frame: 4 months

  2. Age

    Age (measured in years) for feasibility purposes

    Time frame: 4 months

  3. Costs for care

    The costs related to the time dedicated by researchers to the study will be calculated in Euros.

    Time frame: 4 months

  4. Costs in stipends

    Costs per participant for care received will be calculated in Euros.

    Time frame: 4 months

  5. Total number of potential participants recruited initially

    The total number of participants recruited at the beginning of the study will be recorded as an outcome in order to calculate Drop-out ratios (dividing the number of participants completing the study by the total number of initially recruited).

    Time frame: 4 months

  6. Total number of potential participants who made contact showing an interest in the study

    The total number of potential participants interested in the study will be recorded as an outcome in order to calculate Recruitment ratio (dividing the number of participants initiating the study by the total number of interested).

    Time frame: 4 months

  7. Total number of participants completing the study

    The number of participants recruited and completing the study will be recorded as an outcome to be later divided by the number of months of the study, in order to calculate the recruitment rate.

    Time frame: 4 months

07

Study locations

1 of 1 sites recruiting
  • Real Centro Universitario María Cristina
    San Lorenzo De El Escorial, Madrid 28200, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05240547
Lead sponsor
Real Centro Universitario Maria Cristina
Responsible party
Sponsor
First posted
Feb 15, 2022
Start date
Feb 14, 2022
Primary completion
May 30, 2024 (estimated)
Completion
Dec 14, 2024 (estimated)
Last update
Nov 18, 2023

Study contacts

Elisa Torres Gonzalez, BSc
Contact
elisa.torres.quiro@gmail.com
918909435
Carlos Gevers Montoro, DC, MSc
principal investigator · RCU María Cristina

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion